Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/39722
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | |
dc.contributor.author | LIN, Sumika M. | |
dc.contributor.author | BORGES, Marcus K. | |
dc.contributor.author | SIQUEIRA, Alaise S. S. de | |
dc.contributor.author | BIELLA, Marina M. | |
dc.contributor.author | JACOB-FILHO, Wilson | |
dc.contributor.author | CESARI, Matteo | |
dc.contributor.author | VOSHAAR, Richard C. Oude | |
dc.contributor.author | APRAHAMIAN, Ivan | |
dc.date.accessioned | 2021-04-15T19:44:24Z | - |
dc.date.available | 2021-04-15T19:44:24Z | - |
dc.date.issued | 2021 | |
dc.identifier.citation | AGING & MENTAL HEALTH, v.25, n.2, p.219-224, 2021 | |
dc.identifier.issn | 1360-7863 | |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/39722 | - |
dc.description.abstract | Objectives: To evaluate whether fall risk in older adults is associated with the use of selective serotonin receptor inhibitor (SSRI) monotherapy among geriatric outpatients, and whether this association is moderated by the presence of depressive disorder and/or frailty. Methods: Prospective cohort study with a 12-month follow-up and including 811 community-dwelling adults aged 60 or older from a university-based Geriatric Outpatient Unit. Major depressive disorder (MDD) was diagnosed according to DSM-5 criteria; subsyndromal depression as not meeting MDD criteria, but a Geriatric Depression Scale 15-item score ? 6 points. Frailty was evaluated with the FRAIL questionnaire. The association between SSRI use, depression, or both as well as the association between SSRI use, frailty, or both with falls were estimated through a generalized estimating equation (GEE) adjusted for relevant confounders. Results: At baseline, 297 patients (36.6%) used a SSRI (82 without remitted depression) and 306 (37.7%) were classified as physically frail. Frailty was more prevalent among SSRI users (44.8% versus 33.7%, p =.004). After 12 months, 179 participants had at least one fall (22.1%). SSRI use, depression as well as frailty were all independently associated with falls during follow-up. Nonetheless, patients with concurrent of SSRI usage and non-remitted depression had no higher risk compared to either remitted SSRI users or depressed patients without SSRIs. In contrast, concurrence of SSRI use and frailty increases the risk of falling substantially above those by SSRI usage or frailty alone. Conclusion: SSRI usage was independently associated with falls. Especially in frail-depressed patients, treatment strategies for depression other than SSRIs should be considered. | eng |
dc.language.iso | eng | |
dc.publisher | ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | eng |
dc.relation.ispartof | Aging & Mental Health | |
dc.rights | restrictedAccess | eng |
dc.subject | Depression | eng |
dc.subject | antidepressants | eng |
dc.subject | frailty | eng |
dc.subject | falls | eng |
dc.subject | older adults | eng |
dc.title | Serotonin receptor inhibitor is associated with falls independent of frailty in older adults | eng |
dc.type | article | eng |
dc.rights.holder | Copyright ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD | eng |
dc.identifier.doi | 10.1080/13607863.2019.1675143 | |
dc.identifier.pmid | 31603040 | |
dc.subject.wos | Geriatrics & Gerontology | eng |
dc.subject.wos | Gerontology | eng |
dc.subject.wos | Psychiatry | eng |
dc.type.category | original article | eng |
dc.type.version | publishedVersion | eng |
hcfmusp.author.external | CESARI, Matteo:Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy | |
hcfmusp.author.external | VOSHAAR, Richard C. Oude:Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Groningen, Netherlands | |
hcfmusp.description.beginpage | 219 | |
hcfmusp.description.endpage | 224 | |
hcfmusp.description.issue | 2 | |
hcfmusp.description.volume | 25 | |
hcfmusp.origem | WOS | |
hcfmusp.origem.id | WOS:000612771800005 | |
hcfmusp.origem.id | 2-s2.0-85074010798 | |
hcfmusp.publisher.city | ABINGDON | eng |
hcfmusp.publisher.country | ENGLAND | eng |
hcfmusp.relation.reference | Almeida OP, 1999, ARQ NEURO-PSIQUIAT, V57, P421, DOI 10.1590/S0004-282X1999000300013 | eng |
hcfmusp.relation.reference | Aprahamian I, 2019, INT PSYCHOGERIATR, V31, P425, DOI 10.1017/S104161021800100X | eng |
hcfmusp.relation.reference | Aprahamian I, 2017, J AM MED DIR ASSOC, V18, DOI 10.1016/j.jamda.2016.12.067 | eng |
hcfmusp.relation.reference | Benraad CEM, 2016, INT J GERIATR PSYCH, V31, P990, DOI 10.1002/gps.4443 | eng |
hcfmusp.relation.reference | Bloch F, 2011, J AGING HEALTH, V23, P329, DOI 10.1177/0898264310381277 | eng |
hcfmusp.relation.reference | Caligiuri MP, 2000, J AFFECT DISORDERS, V57, P83, DOI 10.1016/S0165-0327(99)00068-3 | eng |
hcfmusp.relation.reference | Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9 | eng |
hcfmusp.relation.reference | Cuijpers P, 2018, COGN BEHAV THERAPY, V47, P91, DOI 10.1080/16506073.2017.1420098 | eng |
hcfmusp.relation.reference | Cuijpers P, 2009, INT PSYCHOGERIATR, V21, P16, DOI 10.1017/S1041610208008089 | eng |
hcfmusp.relation.reference | Deandrea S, 2010, EPIDEMIOLOGY, V21, P658, DOI 10.1097/EDE.0b013e3181e89905 | eng |
hcfmusp.relation.reference | Durso DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083926 | eng |
hcfmusp.relation.reference | Fillit H, 2009, J AM GERIATR SOC, V57, P348, DOI 10.1111/j.1532-5415.2008.02104.x | eng |
hcfmusp.relation.reference | FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6 | eng |
hcfmusp.relation.reference | Fried LP, 2004, J GERONTOL A-BIOL, V59, P255 | eng |
hcfmusp.relation.reference | Gebara MA, 2015, AM J GERIAT PSYCHIAT, V23, P1016, DOI 10.1016/j.jagp.2014.11.004 | eng |
hcfmusp.relation.reference | HALPER JP, 1988, BRIT J PSYCHIAT, V153, P87, DOI 10.1192/S0007125000297341 | eng |
hcfmusp.relation.reference | Hayashi T, 2019, GERIATR GERONTOL INT, V19, P508, DOI 10.1111/ggi.13650 | eng |
hcfmusp.relation.reference | Judd LL, 1998, ARCH GEN PSYCHIAT, V55, P694, DOI 10.1001/archpsyc.55.8.694 | eng |
hcfmusp.relation.reference | KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016 | eng |
hcfmusp.relation.reference | Kerse N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002423 | eng |
hcfmusp.relation.reference | Kokkeler KJE, 2019, INT J GERIATR PSYCH, V34, P1226, DOI 10.1002/gps.5121 | eng |
hcfmusp.relation.reference | Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209 | eng |
hcfmusp.relation.reference | LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179 | eng |
hcfmusp.relation.reference | Lin SM, 2018, J AM MED DIR ASSOC, V19, P310, DOI 10.1016/j.jamda.2017.10.017 | eng |
hcfmusp.relation.reference | Lohman M, 2016, J GERONTOL B-PSYCHOL, V71, P630, DOI 10.1093/geronb/gbu180 | eng |
hcfmusp.relation.reference | Nelson JC, 2013, AM J PSYCHIAT, V170, P651, DOI 10.1176/appi.ajp.2012.12070927 | eng |
hcfmusp.relation.reference | Pena SDJ, 2009, BRAZ J MED BIOL RES, V42, P870, DOI 10.1590/S0100-879X2009005000026 | eng |
hcfmusp.relation.reference | Phelan EA, 2018, ANN INTERN MED, V169, pITC81, DOI 10.7326/AITC201812040 | eng |
hcfmusp.relation.reference | Radcliff S, 2015, J AM GERIATR SOC, V63, P2227, DOI 10.1111/jgs.13702 | eng |
hcfmusp.relation.reference | RAY WA, 1992, J CLIN PSYCHOPHARM, V12, P386 | eng |
hcfmusp.relation.reference | Soysal P, 2017, AGEING RES REV, V36, P78, DOI 10.1016/j.arr.2017.03.005 | eng |
hcfmusp.relation.reference | Szlejf C, 2019, J AM MED DIR ASSOC, V20, P1641, DOI 10.1016/j.jamda.2018.09.020 | eng |
hcfmusp.relation.reference | Van Kan GA, 2008, J NUTR HEALTH AGING, V12, P29, DOI 10.1007/BF02982161 | eng |
hcfmusp.relation.reference | Wernicke JF, 2005, DRUG SAFETY, V28, P1057, DOI 10.2165/00002018-200528110-00006 | eng |
hcfmusp.relation.reference | Woolcott JC, 2009, ARCH INTERN MED, V169, P1952, DOI 10.1001/archinternmed.2009.357 | eng |
dc.description.index | MEDLINE | eng |
dc.identifier.eissn | 1364-6915 | |
hcfmusp.citation.scopus | 8 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MCM Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/66 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_LIN_Serotonin_receptor_inhibitor_is_associated_with_falls_independent_2021.PDF Restricted Access | publishedVersion (English) | 1.37 MB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.